<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508164/" ref="ordinalpos=210&amp;ncbi_uid=5657097&amp;link_uid=PMC3508164" image-link="/pmc/articles/PMC3508164/figure/F9/" class="imagepopup">Fig. 9.  From: Cripto-1 enhances the canonical Wnt/?-catenin <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> by binding to LRP5 and LRP6 co-receptors. </a></div><br /><div class="p4l_captionBody">Activation of the canonical Wnt/Î²-catenin signaling pathway is independent of a Smad2/3 signaling pathway in F9 cells. (A) Western blot analysis for phospho Smad2 (P-Smad2) and total Smad2 in F9 and F9 Cripto-1-/- cells stimulated with rhWnt3a (10 ng/ml) in the presence or absence of SB431542 inhibitor. Density ratio indicates densitometric values of phosphorylated Smad2/total Smad2. (B) SuperTOPFLASH luciferase reporter assay and (C) (n2)7-luc reporter assay in F9 and F9 Cripto-1-/- cells. Cells were incubated in the presence of the Alk4/5/7 inhibitor SB431542 to block activation of the Smad2/Smad3 signaling pathway.</div></div>